- Pfizer and its partner BioNTech said that while two doses may not be
protective enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of
virus-fighting antibodies against the omicron variant.
Scientists don't yet know how big a threat the omicron variant really is.
Currently the extra-contagious delta variant is responsible for most of
the COVID-19 cases in the U.S. and other countries.
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Monday, December 13, 2021
Pfizer says COVID booster offers protection against omicron
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment